SINULIEF Trademark

Trademark Overview


On Wednesday, July 17, 2024, a trademark application was filed for SINULIEF with the United States Patent and Trademark Office. The USPTO has given the SINULIEF trademark a serial number of 98653939. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, April 7, 2026. This trademark is owned by RoseWell Pharmaceuticals LLC. The SINULIEF trademark is filed in the Pharmaceutical Products category with the following description:

Antihistamines; Allergy medications; Allergy relief medication; Antiallergic medicines; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations for treating allergies
sinulief

General Information


Serial Number98653939
Word MarkSINULIEF
Filing DateWednesday, July 17, 2024
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, April 7, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 16, 2025

Trademark Statements


Goods and ServicesAntihistamines; Allergy medications; Allergy relief medication; Antiallergic medicines; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations for treating allergies
Pseudo MarkSINU LIEF SINUS RELIEF

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 17, 2024
Primary Code005
First Use Anywhere DateFriday, May 9, 2025
First Use In Commerce DateFriday, May 9, 2025

Trademark Owner History


Party NameRoseWell Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92128-2538
US

Party NameRoseWell Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92128-2538
US

Trademark Events


Event DateEvent Description
Thursday, July 18, 2024NEW APPLICATION ENTERED
Thursday, February 6, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 7, 2025ASSIGNED TO EXAMINER
Friday, February 7, 2025NON-FINAL ACTION WRITTEN
Friday, February 7, 2025NON-FINAL ACTION E-MAILED
Friday, February 7, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 6, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, May 6, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, August 7, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 8, 2025SUSPENSION LETTER WRITTEN
Friday, August 8, 2025LETTER OF SUSPENSION E-MAILED
Friday, August 8, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 15, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 10, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 16, 2025PUBLISHED FOR OPPOSITION
Tuesday, September 16, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, November 16, 2025TEAS STATEMENT OF USE RECEIVED
Friday, November 21, 2025TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, March 27, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, November 16, 2025USE AMENDMENT FILED
Friday, March 27, 2026STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 7, 2026ASSIGNED TO EXAMINER
Tuesday, April 7, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 7, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED